{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T21:29:48Z","timestamp":1784064588068,"version":"3.55.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,13]]},"DOI":"10.7759\/cureus.45148","type":"journal-article","created":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T10:15:38Z","timestamp":1694600138000},"source":"Crossref","is-referenced-by-count":3,"title":["Tumor-Infiltrating Lymphocytes and Tumor-Stroma Ratio on Early-Stage Cervix Carcinoma: Prognostic Value of Two Distinct Morphological Patterns of Microenvironment"],"prefix":"10.7759","author":[{"given":"Ailma","family":"Larre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel C","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovana J","family":"Gerbasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filomena M","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01670-1","article-title":"Targeting the tumor stroma for cancer therapy","volume":"21","author":"Xu M","year":"2022","unstructured":"Xu M, Zhang T, Xia R, Wei Y, Wei X. Targeting the tumor stroma for cancer therapy. Mol Cancer. 2022, 21:208. 10.1186\/s12943-022-01670-1","journal-title":"Mol Cancer"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan D","year":"2022","unstructured":"Hanahan D. Hallmarks of cancer: new dimensions. Cancer Discov. 2022, 12:31-46. 10.1158\/2159-8290.CD-21-1059","journal-title":"Cancer Discov"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-020-00656-y","article-title":"Prognostic value of desmoplastic stroma in intrahepatic cholangiocarcinoma","volume":"34","author":"Guedj N","year":"2021","unstructured":"Guedj N, Blaise L, Cauchy F, Albuquerque M, Soubrane O, Paradis V. Prognostic value of desmoplastic stroma in intrahepatic cholangiocarcinoma. Mod Pathol. 2021, 34:408-16. 10.1038\/s41379-020-00656-y","journal-title":"Mod Pathol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-022-10183-5","article-title":"Tumour stroma ratio is a potential predictor for 5-year disease-free survival in breast cancer","volume":"22","author":"Yan D","year":"2022","unstructured":"Yan D, Ju X, Luo B, Guan F, He H, Yan H, Yuan J. Tumour stroma ratio is a potential predictor for 5-year disease-free survival in breast cancer. BMC Cancer. 2022, 22:1082. 10.1186\/s12885-022-10183-5","journal-title":"BMC Cancer"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/his.14070","article-title":"Prognostication for oral squamous cell carcinoma patients based on the tumour-stroma ratio and tumour budding","volume":"76","author":"Dourado MR","year":"2020","unstructured":"Dourado MR, Miwa KY, Hamada GB, et al.. Prognostication for oral squamous cell carcinoma patients based on the tumour-stroma ratio and tumour budding. Histopathology. 2020, 76:906-18. 10.1111\/his.14070","journal-title":"Histopathology"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-022-02249-y","article-title":"Tumor-stroma ratio can predict lymph-node metastasis in cT1\/2N0 oral tongue squamous cell carcinoma independent of tumor budding grade","volume":"27","author":"Sakai T","year":"2022","unstructured":"Sakai T, Saito Y, Tateishi Y, et al.. Tumor-stroma ratio can predict lymph-node metastasis in cT1\/2N0 oral tongue squamous cell carcinoma independent of tumor budding grade. Int J Clin Oncol. 2022, 27:1818-27. 10.1007\/s10147-022-02249-y","journal-title":"Int J Clin Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol29050263","article-title":"Tumor stroma ratio and its significance in locally advanced colorectal cancer","volume":"29","author":"Sullivan L","year":"2022","unstructured":"Sullivan L, Pacheco RR, Kmeid M, Chen A, Lee H. Tumor stroma ratio and its significance in locally advanced colorectal cancer. Curr Oncol. 2022, 29:3232-41. 10.3390\/curroncol29050263","journal-title":"Curr Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s00384-021-04023-4","article-title":"Tumour-stroma ratio outperforms tumour budding as biomarker in colon cancer: a cohort study","volume":"36","author":"Smit MA","year":"2021","unstructured":"Smit MA, van Pelt GW, Terpstra V, Putter H, Tollenaar RA, Mesker WE, van Krieken JH. Tumour-stroma ratio outperforms tumour budding as biomarker in colon cancer: a cohort study. Int J Colorectal Dis. 2021, 36:2729-37. 10.1007\/s00384-021-04023-4","journal-title":"Int J Colorectal Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2019.12.022","article-title":"The tumor-stroma ratio is an independent predictor of survival in patients with 2018 FIGO stage IIIC squamous cell carcinoma of the cervix following primary radical surgery","volume":"156","author":"Zong L","year":"2020","unstructured":"Zong L, Zhang Q, Kong Y, et al.. The tumor-stroma ratio is an independent predictor of survival in patients with 2018 FIGO stage IIIC squamous cell carcinoma of the cervix following primary radical surgery. Gynecol Oncol. 2020, 156:676-81. 10.1016\/j.ygyno.2019.12.022","journal-title":"Gynecol Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2013.11.003","article-title":"Tumor-stroma ratio is an independent predictor for survival in early cervical carcinoma","volume":"132","author":"Liu J","year":"2014","unstructured":"Liu J, Liu J, Li J, et al.. Tumor-stroma ratio is an independent predictor for survival in early cervical carcinoma. Gynecol Oncol. 2014, 132:81-6. 10.1016\/j.ygyno.2013.11.003","journal-title":"Gynecol Oncol"},{"key":"ref11","article-title":"Revised FIGO staging for carcinoma of the cervix","volume":"105","author":"Pecorelli S","year":"2009","unstructured":"Pecorelli S, Zigliani L, Odicino F. Revised FIGO staging for carcinoma of the cervix. Int J Gynaecol Obstet. 2009, 105:107-8. 1016\/j.ijgo.2009.02.009","journal-title":"Int J Gynaecol Obstet"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/PGP.0b013e31829952c6","article-title":"Invasive endocervical adenocarcinoma: proposal for a new pattern-based classification system with significant clinical implications: a multi-institutional study","volume":"32","author":"Diaz De Vivar A","year":"2013","unstructured":"Diaz De Vivar A, Roma AA, Park KJ, et al.. Invasive endocervical adenocarcinoma: proposal for a new pattern-based classification system with significant clinical implications: a multi-institutional study. Int J Gynecol Pathol. 2013, 32:592-601. 10.1097\/PGP.0b013e31829952c6","journal-title":"Int J Gynecol Pathol"},{"key":"ref13","article-title":"Histology for pathologists","author":"Mills SE","year":"2019","unstructured":"Mills SE. Histology for pathologists. LWW. 2019,","journal-title":"LWW"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000232","article-title":"Histologic categorization of fibrotic cancer stroma in the primary tumor is an independent prognostic index in resectable colorectal liver metastasis","volume":"38","author":"Ueno H","year":"2014","unstructured":"Ueno H, Konishi T, Ishikawa Y, et al.. Histologic categorization of fibrotic cancer stroma in the primary tumor is an independent prognostic index in resectable colorectal liver metastasis. Am J Surg Pathol. 2014, 38:1380-6. 10.1097\/PAS.0000000000000232","journal-title":"Am J Surg Pathol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdu450","article-title":"The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014","volume":"26","author":"Salgado R","year":"2015","unstructured":"Salgado R, Denkert C, Demaria S, et al.. The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014. Ann Oncol. 2015, 26:259-71. 10.1093\/annonc\/mdu450","journal-title":"Ann Oncol"},{"key":"ref16","article-title":"Incid\u00eancia de C\u00e2ncer no Brasil. (2022). Accessed: 21\/04","author":"Estimativa 2023","year":"2023","unstructured":"Estimativa 2023. Incid\u00eancia de C\u00e2ncer no Brasil. (2022). Accessed: 21\/04. 2023."},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1200\/GO.20.00099","article-title":"Panorama of Gynecologic Cancer in Brazil","volume":"6","author":"Paulino E","year":"2020","unstructured":"Paulino E, de Melo AC, Silva-Filho AL, Maciel LF, Thuler LC, Goss P, Nogueira-Rodrigues A. Panorama of Gynecologic Cancer in Brazil. JCO Glob Oncol. 2020, 6:1617-30. 10.1200\/GO.20.00099","journal-title":"JCO Glob Oncol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14184458","article-title":"Review Article: Immune Landscape and Immunotherapy Options in Cervical Carcinoma","volume":"14","author":"Kousar K","year":"2022","unstructured":"Kousar K, Ahmad T, Naseer F, Kakar S, Anjum S. Review Article: Immune Landscape and Immunotherapy Options in Cervical Carcinoma. Cancers (Basel). 2022, 14:10.3390\/cancers14184458","journal-title":"Cancers (Basel)"},{"key":"ref19","article-title":"Robbins and Cotran Pathologic Basis of Disease. In Robbins Pathology. Tenth edition","volume":"1","author":"Kumar V","year":"2020","unstructured":"Kumar V, Abbas AK, Aster JC. Robbins and Cotran Pathologic Basis of Disease. In Robbins Pathology. Tenth edition. edition. 2020, 1:1391.","journal-title":"edition"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1159\/000464353","article-title":"PD-1\/PD-L1 Pathway in Breast Cancer","volume":"40","author":"Sch\u00fctz F","year":"2017","unstructured":"Sch\u00fctz F, Stefanovic S, Mayer L, von Au A, Domschke C, Sohn C. PD-1\/PD-L1 Pathway in Breast Cancer. Oncol Res Treat. 2017, 40:294-7. 10.1159\/000464353","journal-title":"Oncol Res Treat"},{"key":"ref21","article-title":"PD-1\/PD-L1 pathway: current researches in cancer","volume":"10","author":"Han Y","year":"2020","unstructured":"Han Y, Liu D, Li L. PD-1\/PD-L1 pathway: current researches in cancer. Am J Cancer Res. 2020, 10:727-742.","journal-title":"Am J Cancer Res"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-021-00346-1","article-title":"The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group","volume":"7","author":"El Bairi K","year":"2021","unstructured":"El Bairi K, Haynes HR, Blackley E, et al.. The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group. NPJ Breast Cancer. 2021, 7:150. 10.1038\/s41523-021-00346-1","journal-title":"NPJ Breast Cancer"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15020376","article-title":"The Tumor Microenvironment in Tumorigenesis and Therapy Resistance Revisited","volume":"15","author":"Dzobo K","year":"2023","unstructured":"Dzobo K, Senthebane DA, Dandara C. The Tumor Microenvironment in Tumorigenesis and Therapy Resistance Revisited. Cancers (Basel). 2023, 15:10.3390\/cancers15020376","journal-title":"Cancers (Basel)"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1111\/odi.14013","article-title":"Tumour-stroma ratio is a valuable prognostic factor for oral tongue squamous cell carcinoma","volume":"29","author":"Kang J","year":"2023","unstructured":"Kang J, Su M, Xu Q, Wang C, Yuan X, Han Z. Tumour-stroma ratio is a valuable prognostic factor for oral tongue squamous cell carcinoma. Oral Dis. 2023, 29:628-38. 10.1111\/odi.14013","journal-title":"Oral Dis"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-022-02049-1","article-title":"The tumour-associated stroma correlates with poor clinical outcomes and immunoevasive contexture in patients with upper tract urothelial carcinoma: results from a multicenter real-world study (TSU-01 Study)","volume":"128","author":"Xu L","year":"2023","unstructured":"Xu L, Zhong W, Li C, et al.. The tumour-associated stroma correlates with poor clinical outcomes and immunoevasive contexture in patients with upper tract urothelial carcinoma: results from a multicenter real-world study (TSU-01 Study). Br J Cancer. 2023, 128:310-20. 10.1038\/s41416-022-02049-1","journal-title":"Br J Cancer"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1177\/2050640620975324","article-title":"Tumour\u2010stroma ratio has poor prognostic value in nonpedunculated T1 colorectal cancer: A multicentre case\u2010cohort study","volume":"9","author":"Dang H","year":"2021","unstructured":"Dang H, van Pelt GW, Haasnoot KJ, et al.. Tumour\u2010stroma ratio has poor prognostic value in nonpedunculated T1 colorectal cancer: A multicentre case\u2010cohort study. United European Gastroenterol J. 2021, 9:478-85. 10.1177\/2050640620975324","journal-title":"United European Gastroenterol J"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15041137","article-title":"Recent Advances in Cervical Cancer Management: A Review on Novel Prognostic Factors in Primary and Recurrent Tumors","volume":"15","author":"Santoro A","year":"2023","unstructured":"Santoro A, Inzani F, Angelico G, et al.. Recent Advances in Cervical Cancer Management: A Review on Novel Prognostic Factors in Primary and Recurrent Tumors. Cancers (Basel). 2023, 15:10.3390\/cancers15041137","journal-title":"Cancers (Basel)"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-022-06687-x","article-title":"Stromal or intraepithelial tumor-infiltrating lymphocytes: which one has more prognostic significance in cervical cancer?","volume":"307","author":"Gultekin M","year":"2023","unstructured":"Gultekin M, Beduk Esen CS, Ates Ozdemir D, Yildirim S, Yuce D, Usubutun A, Yildiz F. Stromal or intraepithelial tumor-infiltrating lymphocytes: which one has more prognostic significance in cervical cancer?. Arch Gynecol Obstet. 2023, 307:969-80. 10.1007\/s00404-022-06687-x","journal-title":"Arch Gynecol Obstet"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2020.07.106","article-title":"Tumor-infiltrating lymphocytes predict survival outcomes in patients with cervical cancer treated with concurrent chemoradiotherapy","volume":"159","author":"Ohno A","year":"2020","unstructured":"Ohno A, Iwata T, Katoh Y, et al.. Tumor-infiltrating lymphocytes predict survival outcomes in patients with cervical cancer treated with concurrent chemoradiotherapy. Gynecol Oncol. 2020, 159:329-34. 10.1016\/j.ygyno.2020.07.106","journal-title":"Gynecol Oncol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2007.08.089","article-title":"A comparative study of the cellular immune response in patients with stage IB cervical squamous cell carcinoma. Low numbers of several immune cell subtypes are strongly associated with relapse of disease within 5 years","volume":"108","author":"Nedergaard BS","year":"2008","unstructured":"Nedergaard BS, Ladekarl M, Nyengaard JR, Nielsen K. A comparative study of the cellular immune response in patients with stage IB cervical squamous cell carcinoma. Low numbers of several immune cell subtypes are strongly associated with relapse of disease within 5 years. Gynecol Oncol. 2008, 108:106-11. 10.1016\/j.ygyno.2007.08.089","journal-title":"Gynecol Oncol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2019.152751","article-title":"Immune stromal features in cervical squamous cell carcinoma are prognostic factors for distant metastasis: A retrospective study","volume":"216","author":"Cao L","year":"2020","unstructured":"Cao L, Sun PL, He Y, Yao M, Gao H. Immune stromal features in cervical squamous cell carcinoma are prognostic factors for distant metastasis: A retrospective study. Pathol Res Pract. 2020, 216:152751. 10.1016\/j.prp.2019.152751","journal-title":"Pathol Res Pract"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)30789-X","article-title":"International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study","volume":"391","author":"Pag\u00e8s F","year":"2018","unstructured":"Pag\u00e8s F, Mlecnik B, Marliot F, et al.. International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study. Lancet. 2018, 391:2128-2139. 10.1016\/S0140-6736(18)30789-X","journal-title":"Lancet"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.3833","article-title":"The immune landscape during the tumorigenesis of cervical cancer","volume":"10","author":"Wang Y","year":"2021","unstructured":"Wang Y, He M, Zhang G, Cao K, Yang M, Zhang H, Liu H. The immune landscape during the tumorigenesis of cervical cancer. Cancer Med. 2021, 10:2380-95. 10.1002\/cam4.3833","journal-title":"Cancer Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/175115-tumor-infiltrating-lymphocytes-and-tumor-stroma-ratio-on-early-stage-cervix-carcinoma-prognostic-value-of-two-distinct-morphological-patterns-of-microenvironment","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:04:50Z","timestamp":1707509090000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/175115-tumor-infiltrating-lymphocytes-and-tumor-stroma-ratio-on-early-stage-cervix-carcinoma-prognostic-value-of-two-distinct-morphological-patterns-of-microenvironment"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,13]]},"references-count":33,"URL":"https:\/\/doi.org\/10.7759\/cureus.45148","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,13]]}}}